Literature DB >> 19129777

Fixing a failed vaccine.

Steven M Varga.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 19129777     DOI： 10.1038/nm0109-21

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  13 in total

1.  Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine.

Authors:  H W Kim; J G Canchola; C D Brandt; G Pyles; R M Chanock; K Jensen; R H Parrott
Journal:  Am J Epidemiol       Date:  1969-04       Impact factor: 4.897

2.  Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus.

Authors:  E A Kurt-Jones; L Popova; L Kwinn; L M Haynes; L P Jones; R A Tripp; E E Walsh; M W Freeman; D T Golenbock; L J Anderson; R W Finberg
Journal:  Nat Immunol       Date:  2000-11       Impact factor: 25.606

3.  A potential molecular mechanism for hypersensitivity caused by formalin-inactivated vaccines.

Authors:  Amin Moghaddam; Wieslawa Olszewska; Belinda Wang; John S Tregoning; Rebecca Helson; Quentin J Sattentau; Peter J M Openshaw
Journal:  Nat Med       Date:  2006-07-23       Impact factor: 53.440

4.  C5 modulates airway hyperreactivity and pulmonary eosinophilia during enhanced respiratory syncytial virus disease by decreasing C3a receptor expression.

Authors:  Guillermina A Melendi; Scott J Hoffman; Ruth A Karron; Pablo M Irusta; Federico R Laham; Alison Humbles; Brian Schofield; Chien-Hsiung Pan; Richard Rabold; Bhagvanji Thumar; Adeep Thumar; Norma P Gerard; Wayne Mitzner; Scott R Barnum; Craig Gerard; Steven R Kleeberger; Fernando P Polack
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

5.  Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA.

Authors:  Sandra S Diebold; Tsuneyasu Kaisho; Hiroaki Hemmi; Shizuo Akira; Caetano Reis e Sousa
Journal:  Science       Date:  2004-02-19       Impact factor: 47.728

6.  MAVS and MyD88 are essential for innate immunity but not cytotoxic T lymphocyte response against respiratory syncytial virus.

Authors:  Vijay G Bhoj; Qinmiao Sun; Elizabeth J Bhoj; Cynthia Somers; Xiang Chen; Juan-Pablo Torres; Asuncion Mejias; Ana M Gomez; Hasan Jafri; Octavio Ramilo; Zhijian J Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-09       Impact factor: 11.205

7.  Enhancement of respiratory syncytial virus pulmonary pathology in cotton rats by prior intramuscular inoculation of formalin-inactiva ted virus.

Authors:  G A Prince; A B Jenson; V G Hemming; B R Murphy; E E Walsh; R L Horswood; R M Chanock
Journal:  J Virol       Date:  1986-03       Impact factor: 5.103

8.  Pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of CD4+ T cells.

Authors:  M Connors; A B Kulkarni; C Y Firestone; K L Holmes; H C Morse; A V Sotnikov; B R Murphy
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

9.  Formalin-inactivated respiratory syncytial virus vaccine induces antibodies to the fusion glycoprotein that are deficient in fusion-inhibiting activity.

Authors:  B R Murphy; E E Walsh
Journal:  J Clin Microbiol       Date:  1988-08       Impact factor: 5.948

10.  Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease.

Authors:  Maria Florencia Delgado; Silvina Coviello; A Clara Monsalvo; Guillermina A Melendi; Johanna Zea Hernandez; Juan P Batalle; Leandro Diaz; Alfonsina Trento; Herng-Yu Chang; Wayne Mitzner; Jeffrey Ravetch; José A Melero; Pablo M Irusta; Fernando P Polack
Journal:  Nat Med       Date:  2008-12-14       Impact factor: 53.440
View more
  7 in total

1.  Sirtuin 1 Regulates Dendritic Cell Activation and Autophagy during Respiratory Syncytial Virus-Induced Immune Responses.

Authors:  Anna B Owczarczyk; Matthew A Schaller; Michelle Reed; Andrew J Rasky; David B Lombard; Nicholas W Lukacs
Journal:  J Immunol       Date:  2015-07-08       Impact factor: 5.422

2.  Viruslike particle vaccine induces protection against respiratory syncytial virus infection in mice.

Authors:  Fu-Shi Quan; Yonghwan Kim; Sujin Lee; Hong Yi; Sang-Moo Kang; Jadranka Bozja; Martin L Moore; Richard W Compans
Journal:  J Infect Dis       Date:  2011-10-01       Impact factor: 5.226

Review 3.  Vaccinomics and a new paradigm for the development of preventive vaccines against viral infections.

Authors:  Gregory A Poland; Inna G Ovsyannikova; Richard B Kennedy; Iana H Haralambieva; Robert M Jacobson
Journal:  OMICS       Date:  2011-07-06

4.  A Recombinant BCG Vaccine Is Safe and Immunogenic in Neonatal Calves and Reduces the Clinical Disease Caused by the Respiratory Syncytial Virus.

Authors:  Fabián E Díaz; Mariana Guerra-Maupome; Paiton O McDonald; Daniela Rivera-Pérez; Alexis M Kalergis; Jodi L McGill
Journal:  Front Immunol       Date:  2021-04-26       Impact factor: 7.561

5.  Sirtuin 1 regulates mitochondrial function and immune homeostasis in respiratory syncytial virus infected dendritic cells.

Authors:  Srikanth Elesela; Susan B Morris; Samanthi Narayanan; Surinder Kumar; David B Lombard; Nicholas W Lukacs
Journal:  PLoS Pathog       Date:  2020-02-27       Impact factor: 6.823

Review 6.  Harnessing Cellular Immunity for Vaccination against Respiratory Viruses.

Authors:  Nicholas W Lukacs; Carrie-Anne Malinczak
Journal:  Vaccines (Basel)       Date:  2020-12-21

Review 7.  The infectious march: the complex interaction between microbes and the immune system in asthma.

Authors:  Terianne Wong; Gary Hellermann; Shyam Mohapatra
Journal:  Immunol Allergy Clin North Am       Date:  2010-11       Impact factor: 3.479
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.